{"member_organisations": "", "identification_number": "169673727443-86", "fields_of_interest": "Research and innovation, Public Health", "head_office_address": "Feodor-Lynen-Str. 23", "full_time_equivalent_fte": "0,25", "person_with_legal_responsibility": "Michael Harder", "inter_groups": "", "financial_year_start_date": "01/01/2017", "grants": "52000", "head_office_country": "Germany", "eu_initiatives": "Stakeholder consultation for the evaluation of eu legislation on blood, tissues and cells", "organisation_name": "corlife", "belgium_office_post_code": "", "number_of_persons_involved": "1", "procurement": "", "section": "II - In-house lobbyists and trade/business/professional associations", "source": "", "belgium_office_address": "", "subsection": "Companies & groups", "belgium_office_phone": "", "number_of_ep_accredited_persons": "", "overall_budget_turnover_as_a_range": "", "belgium_office_city": "", "persons_accredited_for_access_to_european_parliament_premises": "", "estimate_of_costs_absolute_amount": "", "registration_date": "09/06/2017", "website_address": "http://www.corlife.eu", "commission_expert_groups_and_other_similar_entities_european_commission": "NA", "head_office_post_box": "", "head_office_city": "Hannover", "membership": "www.bpi.de", "head_office_post_code": "30625", "goals__remit": "Corlife entwickelt und produziert am Firmensitz in Hannover innovative Produkte f\u00fcr die Herzchirurgie. Das Hauptaugenmerk liegt dabei auf zellfreie, regenerative Gewebeimplantate, die vor allem bei der Korrektur angeborener Herzfehler angewendet werden.", "industry_forums": "", "head_office_phone": "(+49)51156353940", "level_of_interest": "European", "relevant_communication": "keine", "financial_year_end_date": "01/12/2017", "estimate_of_costs_as_a_range": "0-9999", "overall_budget_turnover_absolute_amount": "0", "legal_status": "oHG", "person_in_charge_of_eu_relations": "Michael Harder", "customers": "", "belgium_office_post_box": "", "position": "Gesch\u00e4ftsf\u00fchrender Gesellschafter"}